Hollywood, here I come

Herman, Matthew
June 2007
Pharmaceutical Representative;Jun2007, Vol. 37 Issue 6, p3
The article discusses various reports published within the issue, including one by Judi Glova on the overview of the online catering world and another by Pam Marinko and Steve Woodruff on the changes made in the selling environment.


Related Articles

  • Pharmaceutical care: Making the transition. Rodgers, Katie // Drug Topics;5/22/95, Vol. 139 Issue 10, p42 

    Focuses on the framework of pharmaceutical care conversion for it to be effective. Need for universal standards to be set for pharmaceutical care within the profession; Pharmacists' venturing into pharmaceutical care in networks; Revamp of methods of continuing education to meet the needs of...

  • MCOs face legislative, legal changes. Wechsler, Jill // Managed Healthcare Executive;Feb2003, Vol. 13 Issue 2, p14 

    Comments on the growth of healthcare spending in the U.S. Campaign for Medicare reform; Cost controls on prescription drug benefits; Factors affecting the increase in healthcare expenditures.

  • Pharmacy board reaches out to Latinos. Ukens, Carol // Drug Topics;11/18/2002, Vol. 146 Issue 22, p34 

    Reports on the efforts of several pharmacy boards to reach out to minority customers. Release of posters by the North Carolina board urging the use of native language in asking for information; Importance of having a linguistic go-between; Challenge in serving Asia customers.

  • What to do about Medicare Part D.  // Nursing Homes: Long Term Care Management;Feb2006, Vol. 55 Issue 2, p26 

    The article presents an excerpt from The Medicare Drug Benefit: Impact on Nursing Facilities," by the California Health Care Foundation.

  • Drug benefits for US elderly should cover wide range of drugs in class.  // PharmacoEconomics & Outcomes News;9/25/2004, Issue 462, p9 

    Discusses research on the importance of wider coverage for the drug benefits of the elderly within each drug class. Reference to a study published in the August 2004 issue of "Prescription Pharmaceuticals and Biotechnology"; Method used to assess the difference between individual drugs in the...

  • The decision to use a PBM is an individual one. Behrends, Todd M. // Managed Healthcare Executive;Jun2001, Vol. 11 Issue 6 

    Examines the pros and cons of pharmacy benefit management (PBM) program in the United States. Purposes of PBM; Tips to determine the efficacy of PBM in controlling an organization's prescription drug cost; Importance of periodic review of PBM; Challenges involved.

  • Meet the CRO/CMO Market.  // Drug Discovery & Development;May2011 Supplement, Vol. 14, p4 

    An introduction is presented in which the editors discuss various reports within the issue on topics including drug discovery, drug development, and contact research organization (cro) general services.

  • DRUG DISCOVERY/LAB SERVICES.  // Drug Discovery & Development;May2011 Supplement, Vol. 14, p9 

    A directory for drug discovery and laboratory services worldwide is presented.

  • CRO GENERAL SERVICES/MANUFACTURING.  // Drug Discovery & Development;May2011 Supplement, Vol. 14, p32 

    A directory for contact research/manufacturing organization (cro/cmo) general services worldwide is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics